Demographics (5)
- AGE_AF - Participant's age at AF diagnosis (phv00482820.v2.p2)
- AGE_BASELINE - Participant's age at baseline (phv00482816.v2.p2)
- AGE_CVD - Participant's age at CVD diagnosis (phv00482818.v2.p2)
- GENDER - Gender of participant (phv00482814.v2.p2)
- SEX - Biological sex (phv00492409.v2.p2)
Race and Ethnicity (1)
- RACE - Race of participant (phv00482815.v2.p2)
Other (18)
- AF_STATUS - Atrial fibrillation case/control status (phv00482819.v2.p2)
- ANALYTE_TYPE - Analyte Type (phv00482823.v2.p2)
- BODY_SITE - Body site where sample was collected (phv00482822.v2.p2)
- CCDG_SAMPLE_ID - Sample ID in the CCDG project (phv00482830.v2.p2)
- CCDG_SAMPLE_ID_alt - Alternate sample ID in the CCDG project (phv00482831.v2.p2)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body. (phv00482810.v2.p2)
- CVD_STATUS - Cardiovascular disease case/control status (phv00482817.v2.p2)
- Funding_Source - Project funding source (phv00482827.v2.p2)
- IS_TUMOR - Tumor status (phv00482829.v2.p2)
- SAMPLE_ID - De-identified Sample ID (phv00482821.v2.p2)
- SAMPLE_ID - Sample ID (phv00482812.v2.p2)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00482828.v2.p2)
- Study_Name - TOPMed-assigned short study name (phv00482824.v2.p2)
- SUBJECT_ID - De-identified Subject ID (phv00482813.v2.p2)
- SUBJECT_ID - Subject ID (phv00482809.v2.p2)
- SUBJECT_ID - Subject ID (phv00482811.v2.p2)
- TOPMed_Phase - TOPMed Phase (phv00482826.v2.p2)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00482825.v2.p2)